Therapeutic agents targeting BAFF and/or APRIL have demonstrated promising clinical potential in systemic lupus erythematosus (SLE), lupus nephritis (LN), and other B cell-related diseases; however, ...

New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...

Magnetic resonance imaging (MRI) findings such as inflammatory-type lesions and myelopathies are significantly associated with attribution of neuropsychiatric (NP) events to systemic lupus ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Sudden joint pain, or arthralgia, can stem from various causes, ranging from viral infections like the flu and COVID-19 to ...

Introduction Mycophenolic acid (MPA) is a primary immunosuppressive agent used in the treatment of lupus nephritis (LN). While therapeutic drug monitoring (TDM) of MPA is well established in organ ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Lupus may increase the risk of stroke but it also can lead to other changes. Neuropsychiatric lupus is a serious complication that leads to headaches, seizures, and other neurological changes. It also ...